Sponsor or institution
Clinical trials and research at Adiutrix Therapeutics
As of November 12, 2026, Find a Trial lists 3 NIH-funded research projects at this institution, with $2.5 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3NIH research projects
NIH-funded research (3)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Platform to block collagen production and create new anti-fibrosis drugs
A new program aims to develop first-in-class drugs that stop scar tissue from forming by targeting collagen production in fibrosis affecting lungs, skin, kidneys, and gut.
-
New medicines to block the collagen enzyme that causes organ scarring
Developing drugs that stop harmful scarring in lungs, skin, kidneys, and intestines by blocking an enzyme needed to make collagen.
-
Developing new treatments for diseases caused by abnormal fibrosis
This study is looking at new ways to treat diseases caused by excessive scarring in organs, like idiopathic pulmonary fibrosis and scleroderma, by understanding how certain cells trigger this scarring, so we can create better treatments that work well and have fewer side effects.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.